NMS (New Medicine Service)
|New Medicines Service (NMS)|
|Full information||Click here for full NMS information|
|Service specification||Click here for the NMS service spec|
|Training requirements||Pharmacists that will provide the service must have the necessary knowledge and skills to do so, with them assessing and declaring their competence by completing the NHS self-assessment form|
|SOP||Contractors must have a Standard Operating Procedure (SOP) in place for the service. A template SOP can be downloaded from the NPA website|
Updated NMS service specification
NHSE&I have today published an updated draft version of the New Medicine Service (NMS) service specification. This service specification is currently working its way through the NHSE&I publication approval process, and the final version will be published in due course.
The updated service specification reflects the expansion of the service, which was one of the agreed outcomes from negotiations for Year 3 of the CPCF.
Community pharmacy contractors meeting the requirements for the provision of the NMS can start providing the expanded service from today (1st September 2021).
The New Medicine Service (NMS) was the fourth Advanced Service to be added to the NHS community pharmacy contract; it commenced on 1st October 2011.
The service provides support for people with long-term conditions newly prescribed a medicine to help improve medicines adherence; it is initially focused on particular patient groups and conditions.
An e-learning package is now available at CPPE New Medicines Service e-learning programme : https://www.cppe.ac.uk/programmes/l/nms-e-01
- NMS Card
- NMS tracker
- PSNC Web Site NMS
- Frequently Asked Questions from GPs_article
- Guide for Pharmacists – GP NMS Briefing
- Guidance for Community Pharmacists
- NMS Top 40 ID Tool
- Workshop Presentation (October 2011)
- Your Hopes, Fears and Ideas
- NMS Contractor Declaration Form
- NMS Dashboard
- NMS Follow Up Worksheet
- NMS Funding Changes Briefing
- NMS Intervention Worksheet
- NMS Patient Leaflet
- NMS Patient Consent Form
- NMS Service Specification
- NMS When is it complete
Guidance for hospital pharmacists, doctors, nurses and NHS managers working in secondary care about community pharmacy services.
Guidance for community pharmacists about how to engage with hospital colleagues.
A standardised referral form that hospital pharmacists and others can complete when a patient is discharged. This includes a feedback section that community pharmacists can send back to the referrer when they have asked for feedback.
A Leaflet (which can be amended for local use) for patients who are leaving hospital which outlines the services that they can receive from their community pharmacy.
Pfizer have sponsored and coordinated a series of virtual training events on the topic of anticoagulants and the benefits that pharmacists can bring to optimising patient care. Over a series of four events, expert speakers will explore topics relating to anticoagulants pertinent to community pharmacists, including the patient journey involved in the Discharge Medicines Service, delivering excellent NMS interventions and improving overall clinical practice in pharmacy. These events are free of charge and will take place on the following evenings:
- Session 1 – Taking the Discharge Medicines Service (DMS) to The Next Level – The Patient Journey Matters – Thursday 21st October 2021 19:15 – 20:45
- Session 2 – The New Medicines Service (NMS) – Connecting All the Pharmacy Sectors – Wednesday 17th November 2021 19:15 – 20:45
- Session 3 – CVDPREVENT: Understanding the New National Audit – The Pharmacist’s Role, Focus & Opportunity – Wednesday 19th January 2022 19:15 – 20:45
- Session 4 – Pulling Together and Driving Clinical Excellence in Practice: Implementation Examples – Wednesday 16th February 2022 19:15 – 20:45
Please see the flyer for further details and to book your place whilst spaces last.
NB: You can attend any or all of the events. These events are provided by an external organisation and are not endorsed by the Devon LPC.
NMS Antidepressant Pilot – Selected pharmacies only
We are still waiting for the national template of the reporting processes, and hoping to start the pilot early in the new year (2023). We are expecting that a webinar will be arranged to walk you through the process. There are training requirements – it would be great if as much of the training is in place and completed prior to go live as possible.
Training will be required for all Community Pharmacies involved in the pilot; this will include the following:-
- CPPE – Consulting with people with mental health problems
- Royal College of Psychiatrists – Antidepressants
- Royal College of Psychiatrists – Anxiety, panic and phobias
- Scenario based education videos